This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stern, D F
Right arrow Articles by Cao, H
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stern, D F
Right arrow Articles by Cao, H

 Previous Article

Mol Cell Biol. 1988 September; 8(9): 3969-3973

Oncogenic activation of p185neu stimulates tyrosine phosphorylation in vivo.

D F Stern, M P Kamps and H Cao

Department of Pathology, Yale University School of Medicine, New Haven, Connecticut 06510.

ABSTRACT

p185, the product of the neu/erbB2 proto-oncogene, is oncogenically activated by a point mutation that substitutes glutamic acid for valine in the transmembrane domain of the protein. We have found that the transforming form of p185 differs from its normal counterpart in inducing increased tyrosine phosphorylation of other proteins in vivo and in having a much shorter half-life. These results support the model that the transforming p185 resembles a ligand-activated receptor.


Mol Cell Biol. 1988 September; 8(9): 3969-3973




This article has been cited by other articles:

  • Kim, K.-K., Lee, J. J., Yang, Y., You, K.-H., Lee, J.-H. (2008). Macrophage inhibitory cytokine-1 activates AKT and ERK-1/2 via the transactivation of ErbB2 in human breast and gastric cancer cells. Carcinogenesis 29: 704-712 [Abstract] [Full Text]  
  • Klos, K. S., Wyszomierski, S. L., Sun, M., Tan, M., Zhou, X., Li, P., Yang, W., Yin, G., Hittelman, W. N., Yu, D. (2006). ErbB2 Increases Vascular Endothelial Growth Factor Protein Synthesis via Activation of Mammalian Target of Rapamycin/p70S6K Leading to Increased Angiogenesis and Spontaneous Metastasis of Human Breast Cancer Cells. Cancer Res. 66: 2028-2037 [Abstract] [Full Text]  
  • DiGiovanna, M. P., Chu, P., Davison, T. L., Howe, C. L., Carter, D., Claus, E. B., Stern, D. F. (2002). Active Signaling by HER-2/neu in a Subpopulation of HER-2/neu-overexpressing Ductal Carcinoma in Situ: Clinicopathological Correlates. Cancer Res. 62: 6667-6673 [Abstract] [Full Text]  
  • Li, L., Shaw, P. E. (2002). Autocrine-mediated Activation of STAT3 Correlates with Cell Proliferation in Breast Carcinoma Lines. J. Biol. Chem. 277: 17397-17405 [Abstract] [Full Text]  
  • Thor, A. D., Liu, S., Edgerton, S., Moore, D. II, Kasowitz, K. M., Benz, C. C., Stern, D. F., DiGiovanna, M. P. (2000). Activation (Tyrosine Phosphorylation) of ErbB-2 (HER-2/neu): A Study of Incidence and Correlation With Outcome in Breast Cancer. JCO 18: 3230-3239 [Abstract] [Full Text]  
  • Allgayer, H., Babic, R., Gruetzner, K. U., Tarabichi, A., Schildberg, F. W., Heiss, M. M. (2000). c-erbB-2 Is of Independent Prognostic Relevance in Gastric Cancer and Is Associated With the Expression of Tumor-Associated Protease Systems. JCO 18: 2201-2209 [Abstract] [Full Text]  
  • Spencer, K. S.R., Graus-Porta, D., Leng, J., Hynes, N. E., Klemke, R. L. (2000). ErbB2 Is Necessary for Induction of Carcinoma Cell Invasion by Erbb Family Receptor Tyrosine Kinases. JCB 148: 385-397 [Abstract] [Full Text]  
  • Ueno, N. T., Bartholomeusz, C., Herrmann, J. L., Estrov, Z., Shao, R., Andreeff, M., Price, J., Paul, R. W., Anklesaria, P., Yu, D., Hung, M.-C. (2000). E1A-mediated Paclitaxel Sensitization in HER-2/neu-overexpressing Ovarian Cancer SKOV3.ip1 through Apoptosis Involving the Caspase-3 Pathway. Clin. Cancer Res. 6: 250-259 [Abstract] [Full Text]  
  • Kim, S.-O., Houtman, J. C. D., Jiang, J., Ruppert, J. M., Bertics, P. J., Frank, S. J. (1999). Growth Hormone-induced Alteration in ErbB-2 Phosphorylation Status in 3T3-F442A Fibroblasts. J. Biol. Chem. 274: 36015-36024 [Abstract] [Full Text]  
  • Wang, Z., Zhang, L., Yeung, T. K., Chen, X. (1999). Endocytosis Deficiency of Epidermal Growth Factor (EGF) Receptor-ErbB2 Heterodimers in Response to EGF Stimulation. Mol. Biol. Cell 10: 1621-1636 [Abstract] [Full Text]  
  • Carraway, K. L. III, Rossi, E. A., Komatsu, M., Price-Schiavi, S. A., Huang, D., Guy, P. M., Carvajal, M. E., Fregien, N., Carraway, C. A. C., Carraway, K. L. (1999). An Intramembrane Modulator of the ErbB2 Receptor Tyrosine Kinase That Potentiates Neuregulin Signaling. J. Biol. Chem. 274: 5263-5266 [Abstract] [Full Text]  
  • Burke, C. L., Stern, D. F. (1998). Activation of Neu (ErbB-2) Mediated by Disulfide Bond-Induced Dimerization Reveals a Receptor Tyrosine Kinase Dimer Interface. Mol. Cell. Biol. 18: 5371-5379 [Abstract] [Full Text]  
  • Chen, L. I., Webster, M. K., Meyer, A. N., Donoghue, D. J. (1997). Transmembrane Domain Sequence Requirements for Activation of the p185c-neu Receptor Tyrosine Kinase. JCB 137: 619-631 [Abstract] [Full Text]  
  • Gilboa, L., Ben-Levy, R., Yarden, Y. (1995). Roles for a Cytoplasmic Tyrosine and Tyrosine Kinase Activity in the Interactions of Neu Receptors with Coated Pits. J. Biol. Chem. 270: 7061-7067 [Abstract] [Full Text]  
  • Lucassen, E, Andres, A., Reichmann, E, Entwistle, A, Noble, M (1994). The effects of the neuN and neuT genes on differentiation and transformation of mammary epithelial cells. J. Cell Sci. 107: 2919-2929 [Abstract]  
  • Yamauchi, T., Yamauchi, N., Ueki, K., Sugiyama, T., Waki, H., Miki, H., Tobe, K., Matsuda, S., Tsushima, T., Yamamoto, T., Fujita, T., Taketani, Y., Fukayama, M., Kimura, S., Yazaki, Y., Nagai, R., Kadowaki, T. (2000). Constitutive Tyrosine Phosphorylation of ErbB-2 via Jak2 by Autocrine Secretion of Prolactin in Human Breast Cancer. J. Biol. Chem. 275: 33937-33944 [Abstract] [Full Text]  
  • Tikhomirov, O., Carpenter, G. (2000). Geldanamycin Induces ErbB-2 Degradation by Proteolytic Fragmentation. J. Biol. Chem. 275: 26625-26631 [Abstract] [Full Text]